# Thymosin α-1

> Studied in immune modulation and resilience contexts.

Source: https://peptides.cafe/peptide/thymosin-alpha-1
Category: Immune Modulation
Tag: Immune

## Mechanism
A 28-amino-acid peptide naturally produced by the thymus. Research indicates it modulates T-cell maturation, dendritic cell function, and innate immune signaling. Approved in several countries (under the name Zadaxin) as an adjunct in hepatitis B/C and certain cancer protocols.

## Research areas
- Chronic viral hepatitis (approved use abroad)
- Vaccine response augmentation
- Immunosenescence
- Adjunct in oncology research

## Common research protocols
- Subcutaneous clinical use: Twice-weekly subcutaneous dosing in approved international indications.

## Study summaries
- "Thymosin alpha 1: a comprehensive review of clinical experience" — Annals of the New York Academy of Sciences (2010): Reviews approved uses and ongoing trials across viral, oncologic, and immune indications.

## Considerations
- Approved in 35+ countries but not FDA-approved in the US.
- Generally well tolerated in published clinical data.
- Requires physician oversight.

## Disclaimer
Educational content only. Not medical advice, diagnosis, or treatment. Most research peptides are not FDA-approved for human therapeutic use. Consult a licensed clinician before any use.